BDI reps are on-call for all your emergency and after-hours ordering. Call 1-800-948-9834
to place an order today.

BDI Pharma is a Verified-Accredited Wholesale Distributor one
of 34 active members of the HDMA, and a
member of HISCI. Always rest assured your product is being handled
with the utmost care and professionalism.
Healthcare doesn't stop with humans. See how our level of expertise has reached
the world of our special friends at www.4legPharma.com
Effective April 1, 2012 through June 30, 2012. Visit the Centers for Medicare
& Medicaid Services for more information.
|
|
Furosemide INJ
| General Information: Furosemide is typically utilized in adult and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephritic syndrome. It is also indicated as adjunctive therapy in acute pulmonary edema as directed by the package insert. For indications, dosing and other information, please refer to the manufacture package insert.
|
| |
| Manufacturer |
Products |
Size |
NDC |
PI |
MSDS |
| Hospira |
Furosemide INJ |
10mg/mL 10mL Ansyr SYR |
00409-1639-10 |
PI |
MSDS |
| |
Furosemide INJ |
10mg/mL 4mL
Ansyr SYR |
00409-9631-04 |
PI |
MSDS |
| |
Furosemide INJ |
100mg 10mL FTV |
00409-6102-10 |
PI |
MSDS |
| |
Furosemide INJ |
20mg 2mL FTV |
00409-6102-02 |
PI |
MSDS |
| |
Furosemide INJ |
40mg 4mL FTV |
00409-6102-04 |
PI |
MSDS |
| American Regent |
Furosemide INJ |
100mg 10mL |
00517-5710-25 |
PI |
MSDS |
| |
Furosemide INJ |
20mg 2mL |
00517-5702-25 |
PI |
MSDS |
| |
Furosemide INJ |
4mg/mL 4mL SDV |
00517-5704-25 |
PI |
MSDS |
|
|
|
| Clinical Data:
For any questions or for further
information related to Furosemide INJ USP Injection,
clinical pharmacology, additional indications and
usages, contraindications,
warnings, precautions, adverse
reactions, dosage,
administration and/or storage
of this product, please
contact
BDI Pharma or
call
1-800-948-9834. |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|